About Us | Contact Us | User Login

  • Home
  • About ForeseeHome
    • Learn More About ForeseeHome
    • Monitoring Process
    • Program Information
    • ForeseeHome FAQs
    • Technology
    • Research
    • Published Research
    • Clinical Trials
      • AREDS2 ForeseeHome Study
      • Wet AMD Monitoring Study
  • Threat of AMD
    • Learn More About the Threat of AMD
    • Dry AMD
    • Wet AMD
    • Importance of Early Detection
    • Inherent Flaws of the Amsler Grid
    • AMD Resources
  • Patient Stories
  • In the News
  • Find a Doctor
    • First Prescriber Sites
    • AREDS2 Study Sites
    • Wet AMD Monitoring Study Sites
CSS Drop Down Menu by PureCSSMenu.com
  • Information for Physicians
    • ForeseeHome Program Information
    • ForeseeHome Physician FAQs
    • Publications
    • Case Studies
    • Physician Testimonials
    • For Current Practices
    • Events
    • Contact Us

TEXT

Home> Information for Physicians > Publications

Publications

Toward Earlier Detection of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
RETINA 2010; 30:1058-1064

Toward Earlier Detection of Choroidal Neovascularization Secondary to Age-Related Macular DegenerationPurpose: The primary purpose of this study was to evaluate the ability of a home device preferential hyperacuity perimeter to discriminate between patients with choroidal neovascularization (CNV) and intermediate age-related macular degeneration (AMD), and the secondary purpose was to investigate the dependence of sensitivity on lesion characteristics.


Methods: All participants were tested with the home device in an unsupervised mode. The first part of this work was retrospective using tests performed by patients with intermediate AMD and newly diagnosed CNV. In the second part, the classifier was prospectively challenged with tests performed by patients with intermediate AMD and newly diagnosed CNV. The dependence of sensitivity on lesion characteristics was estimated with tests performed by patients with CNV of both parts.


Results: In 66 eyes with CNV and 65 eyes with intermediate AMD, both sensitivity and specificity were 0.85. In the retrospective part (34 CNV and 43 intermediate AMD), sensitivity and specificity were 0.85 6 0.12 (95% confidence interval) and 0.84 6 0.11 (95% confidence interval), respectively. In the prospective part (32 CNV and 22 intermediate AMD), sensitivity and specificity were 0.84 6 0.13 (95% confidence interval) and 0.86 6 0.14 (95% confidence interval), respectively. Chi-square analysis showed no dependence of sensitivity on type (P = 0.44), location (P = 0.243), or size (P = 0.73) of the CNV lesions.


Conclusion: A home device preferential hyperacuity perimeter has good sensitivity and specificity in discriminating between patients with newly diagnosed CNV and intermediate AMD. Sensitivity is not dependent on lesion characteristics.

 

 


Nortal Vision


 

 

© Copyright 2011 Notal VisionTM | Terms & Conditions | Privacy Policy | Customer Support Center: (888) 910-2020

Like us on Facebook Subscribe to our YouTube Channel